1. Alghamdi IG, Hussain II, Alghamdi MS, El-Sheemy MA. The incidence rate of corpus uteri cancer among females in Saudi Arabia: an observational descriptive epidemiological analysis of data from Saudi Cancer Registry 2001–2008. Int J Womens Health. 2014; 6:141–147.
2. Santos P, Cunha TM. Uterine sarcomas: clinical presentation and MRI features. Diagn Interv Radiol. 2015; 21:4–9.
Article
3. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015; 65:5–29.
Article
4. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015; 136:E359–E386.
Article
5. American Cancer Society. Cancer facts & figures 2013. Atlanta (GA): American Cancer Society;2013.
6. Mansori K, Khateri S, Moradi Y, Khazaei Z, Mirzaei H, Hanis SM, et al. Prevalence of obesity and overweight in Iranian children aged less than 5 years: a systematic review and meta-analysis. Korean J Pediatr. 2019; 62:206–212.
Article
7. Friedenreich CM, Neilson HK, Lynch BM. State of the epidemiological evidence on physical activity and cancer prevention. Eur J Cancer. 2010; 46:2593–2604.
Article
8. Cust AE. Physical activity and gynecologic cancer prevention. Recent Results Cancer Res. 2011; 186:159–185.
Article
9. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68:394–424.
Article
10. Chaichian S, Khateri S, Moradi Y, Shadmani FK, Mansori K, Khazaei Z, et al. Trends in cervical cancer incidence in Iran from 2003 to 2009. Middle East J Cancer. 2017; 9:57–63.
11. Torres-Cintrón M, Ortiz AP, Ortiz-Ortiz KJ, Figueroa-Vallés NR, Pérez-Irizarry J, Díaz-Medina G, et al. Using a socioeconomic position index to assess disparities in cancer incidence and mortality, Puerto Rico, 1995–2004. Prev Chronic Dis. 2012; 9:E15.
Article
12. Ghoncheh M, Mohammadian-Hafshejani A, Salehiniya H. Incidence and mortality of breast cancer and their relationship to development in Asia. Asian Pac J Cancer Prev. 2015; 16:6081–6087.
Article
13. Goodarzi E, Moslem A, Feizhadad H, Jarrahi AM, Adineh HA, Sohrabivafa M, et al. Epidemiology, incidence and mortality of thyroid cancer and their relationship with the human development index in the world: an ecology study in 2018. Adv Hum Biol. 2019; 9:162–167.
14. Trinh QD, Schmitges J, Sun M, Sammon J, Shariat SF, Zorn K, et al. Morbidity and mortality of radical prostatectomy differs by insurance status. Cancer. 2012; 118:1803–1810.
Article
15. Davoodi M, Bahadoram S, Bahadoram M, Barahman M, Khazaei Z, Amiri M. Impact of cancers on the kidney function and structure; an ignored entity. J Renal Inj Prev. 2018; 7:112–115.
Article
16. Goodarzi E, Ghorat F, Mosavi Jarrahi A, Adineh HA, Sohrabivafa M, Khazaei Z. Global incidence and mortality of liver cancers and its relationship with the human development index (HDI): an ecology study in 2018. World Cancer Res J. 2019; 6:e1255.
18. Khazaei Z, Ghorat F, Jarrahi AM, Adineh HA, Sohrabivafa M, Goodarzi E. Global incidence and mortality of skin cancer by histological subtype and its relationship with the human development index (HDI); an ecology study in 2018. World Cancer Res J. 2019; 6:e1265.
19. Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the Human Development Index (2008–2030): a population-based study. Lancet Oncol. 2012; 13:790–801.
Article
20. Khazaei S, Rezaeian S, Khazaei Z, Molaeipoor L, Nematollahi S, Lak P, et al. National Breast cancer mortality and incidence rates according to the human development index: an ecological study. Adv Breast Cancer Res. 2016; 5:30–36.
Article
21. United Nations Development Programme. Human Development Report 2016. New York (NY): United Nations Development Programme;2016. cited 2018 Jan 17. Available from:
http://www.hdr.undp.org/en.
22. Khazaei Z, Mosavi Jarrahi A, Momenabadi V, Ghorat F, Adineh HA, Sohrabivafa M, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide stomach cancers and their relationship with the human development index (HDI). World Cancer Res J. 2019; 6:e1257.
23. Banas T, Juszczyk G, Pitynski K, Nieweglowska D, Ludwin A, Czerw A. Incidence and mortality rates in breast, corpus uteri, and ovarian cancers in Poland (1980–2013): an analysis of population-based data in relation to socioeconomic changes. Onco Targets Ther. 2016; 9:5521–5530.
24. Sankaranarayanan R, Ferlay J. Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol. 2006; 20:207–225.
Article
25. Zhang Y, Liu H, Yang S, Zhang J, Qian L, Chen X. Overweight, obesity and endometrial cancer risk: results from a systematic review and meta-analysis. Int J Biol Markers. 2014; 29:e21–9.
Article
26. Khazaei Z, Hasanpour Dehkordi A, Amiri M, Adineh HA, Sohrabivafa M, Darvishi I, et al. The incidence and mortality of endometrial cancer and its association with body mass index and human development index in Asian population. World Cancer Res J. 2018; 5:e1174.
27. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013; 49:1374–1403.
Article
28. Jamison PM, Noone AM, Ries LA, Lee NC, Edwards BK. Trends in endometrial cancer incidence by race and histology with a correction for the prevalence of hysterectomy, SEER 1992 to 2008. Cancer Epidemiol Biomarkers Prev. 2013; 22:233–241.
Article
29. Wartko P, Sherman ME, Yang HP, Felix AS, Brinton LA, Trabert B. Recent changes in endometrial cancer trends among menopausal-age U.S. women. Cancer Epidemiol. 2013; 37:374–377.
Article
30. Kuehn B. Uterine Cancer Concern. JAMA. 2019; 321:336.
Article
31. Lindemann K, Vatten LJ, Ellstrøm-Engh M, Eskild A. Body mass, diabetes and smoking, and endometrial cancer risk: a follow-up study. Br J Cancer. 2008; 98:1582–1585.
Article
32. Dossus L, Allen N, Kaaks R, Bakken K, Lund E, Tjonneland A, et al. Reproductive risk factors and endometrial cancer: the European prospective investigation into cancer and nutrition. Int J Cancer. 2010; 127:442–451.
Article
33. Renehan AG, Soerjomataram I, Tyson M, Egger M, Zwahlen M, Coebergh JW, et al. Incident cancer burden attributable to excess body mass index in 30 European countries. Int J Cancer. 2010; 126:692–702.
Article
34. Shields M, Connor Gorber S, Tremblay MS. Estimates of obesity based on self-report versus direct measures. Health Rep. 2008; 19:61–76.
35. Momenimovahed Z, Ghoncheh M, Pakzad R, Hasanpour H, Salehiniya H. Incidence and mortality of uterine cancer and relationship with human development index in the world. Cukurova Med J. 2017; 42:233–240.